Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 12, Issue 5, Pages 729-740
Publisher
Informa Healthcare
Online
2013-04-08
DOI
10.1517/14740338.2013.789017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted therapy in brain metastasis
- (2012) Riccardo Soffietti et al. CURRENT OPINION IN ONCOLOGY
- Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial
- (2012) Anna Maria Di Giacomo et al. LANCET ONCOLOGY
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting
- (2011) Athanassios P. Kyritsis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?
- (2011) Raffaele Addeo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Lecture: fotemustine in brain tumors
- (2011) A. Silvani et al. NEUROLOGICAL SCIENCES
- Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis Factors
- (2010) M. Del Vecchio et al. CLINICAL CANCER RESEARCH
- Whole-Brain Radiation Therapy Plus Concomitant Temozolomide for the Treatment of Brain Metastases From Non–Small-Cell Lung Cancer: A Randomized, Open-Label Phase II Study
- (2010) Daniel Chua et al. Clinical Lung Cancer
- Therapy and prophylaxis of brain metastases
- (2010) Yvonne Kienast et al. Expert Review of Anticancer Therapy
- Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer
- (2010) Kevin C. De Braganca et al. JOURNAL OF NEURO-ONCOLOGY
- A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma
- (2010) Raffaele Addeo et al. JOURNAL OF NEURO-ONCOLOGY
- Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: A multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603)
- (2010) D. Galetta et al. LUNG CANCER
- Proton inactivation of melanoma cells enhanced by fotemustine
- (2010) A. Ristic-Fira et al. RADIATION PROTECTION DOSIMETRY
- The safety of temozolomide in the treatment of malignancies
- (2009) Van Anh Trinh et al. Expert Opinion On Drug Safety
- The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
- (2009) Laurie E. Gaspar et al. JOURNAL OF NEURO-ONCOLOGY
- O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers
- (2009) Pei-Fang Wu et al. LUNG CANCER
- Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients
- (2009) Laura Ridolfi et al. MELANOMA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now